Skip to main content
A

AbClon Inc. — Investor Relations & Filings

Ticker · 174900 ISIN · KR7174900001 KO Manufacturing
Open in API
Filings indexed 252 across all filing types
Latest filing 2026-03-04 Investor Presentation
Country KR South Korea
Listing KO 174900

About AbClon Inc.

https://www.abclon.com/en/

AbClon Inc. is a clinical-stage company focused on the research and development of antibody-based therapeutics. The company leverages three core proprietary platforms. The CAR-T platform develops personalized cell therapies for cancer patients by engineering a patient's own immune cells to target and destroy cancer cells, with a focus on blood cancers. The NEST (Novel Epitope Screening Technology) platform is designed to discover antibodies that target unique, previously unaddressed sites on disease proteins, enabling novel therapeutic effects. The AffiMab platform facilitates the development of bispecific antibodies that can simultaneously engage two different disease targets, aiming to maximize therapeutic efficacy in refractory diseases.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Investor Presentation Classification · 1% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (Corporate Day). It provides details such as the date, location, purpose, and agenda for the meeting. Since it is an announcement of an event rather than the presentation slides themselves, and it serves as a regulatory notification of corporate activity, it fits best under the 'Regulatory Filings' category as it is a standard disclosure of an IR event schedule.
2026-03-04 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company AbClon. It outlines the date, location, and agenda items (such as financial statement approval, director re-election, and business purpose changes). This type of document is a standard proxy solicitation material sent to shareholders to inform them of upcoming meeting details and request their participation/votes, which falls under the Proxy Solicitation & Information Statement category.
2026-02-27 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for AbClon Inc. It details the meeting date, location, agenda items (such as financial statement approval, director re-election, and stock option grants), and information regarding electronic voting. This document is a standard proxy solicitation material sent to shareholders to inform them of an upcoming meeting and request their votes, which aligns with the definition of a Proxy Solicitation & Information Statement.
2026-02-27 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy) and contains detailed information regarding the upcoming Annual General Meeting (AGM) of AbClon Inc., including the meeting date, agenda items (such as approval of financial statements, appointment of directors, etc.), and instructions for shareholders to exercise their voting rights via electronic proxy or in-person attendance. This document is a formal proxy solicitation material sent to shareholders to request their votes for the meeting.
2026-02-27 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Audit Report / Information Classification · 1% confidence The document is a regulatory filing from a Korean company (AbClon) reporting a significant change (over 30%) in revenue or profit/loss structure. This is a standard mandatory disclosure filing in the Korean market (DART system) used to announce preliminary financial results before the final audit report is finalized. Since it provides specific financial highlights and performance metrics for the fiscal year, it falls under the category of an Earnings Release (ER). FY 2025
2026-01-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (often referred to as a 'Section 16' equivalent in the US) where company insiders report their shareholdings and changes in ownership. Based on the provided filing definitions, this falls under 'Director's Dealing' (DIRS), which covers personal share transactions by company directors and executives.
2026-01-08 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.